LypMedication with Eucalyptus
Natural health product licensed in Canada
- Licence holder
- LPNA Group, Inc. d/b/a Lornamead Products
- NPN or DIN-HM
- 80008901
- Status
- Inactive licence
- Licence date
- 5 December 2008
- Revision date
- Not provided
- Form
- Bâtonnet
- Route of administration
- Topique
- Application type
- TPD Cat IV/LS
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Menthol | 0.36 % (p/p) |
| Camphre | 0.6 % (p/p) |
Non-medicinal ingredients
Aloe Barbadensis Leaf Extract, Bisabolol, extrait de fleur de Lavendula angustifolia (lavande), Cire d'abeille, Chamomilla Recutita (Matricaria) Flower Extract, Bixa orellana, Ethylene/Propylene/styrene copolymer, Butyrospermum parkii, Pentaerythrityl tetracaprate, Polyisobutylene, Allantoïne, Acétate de tocophérol, Melaleuca alternifolia, Diméthicone, Pentaerythrityl Tetracaprylate, Pétrolatum, Hydrogenated Polyisobutene, (p)-hydroxybenzoate de propyle, Dioxyde de titane, Extrait de feuille d'eucalyptus globulus, Butylene/ethylene/styrene Copolymer
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years | Not specified | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
| Adultes | Not specified | Not specified | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Topical analgesic; For temporary relief of pain of minor skin irritations.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80008901
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.